Lifespan Health and Aging
Featured Topics
Lead story
Other featured articles
-
Future Health Dividends for California: Valuing Medical Innovations
Reducing the incidence of four common cancers (breast, colon, lung, and prostate cancer), diabetes and stroke by 50 percent would generate nearly $900 billion in social value for California between 2018 and 2040. Just a 10 percent decline generates $175 billion over the same period.
Posted in -
Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes?
This study provides the first evidence to our knowledge that near-universal access to Medicare at age 65 is associated with improvements in population-level cancer mortality, and provides new evidence on the differences in the impact of health insurance by gender.
Posted in -
Trends in the Price per Median and Mean Life-Year Gained Among Newly Approved Cancer Therapies 1995 to 2017
High and rising launch prices of new cancer drugs have raised American public stakeholder and policy concern. A key policy question is whether the clinical gains offered by these drugs in treating specific cancer indications justify the price increases.
Posted in -
Measuring Alzheimer’s Disease and Other Dementias in Diverse Populations Using Medicare Claims Data
The researchers examined how methods used for identifying dementia in administrative claims affected dementia incidence across racial/ethnic populations using a 100% sample of Medicare beneficiaries.
Posted in
About this section
People are living longer, which brings obvious benefits as well as considerable challenges — from Alzheimer’s and other age-related diseases to increased injuries, disabilities and poverty risks. Policymakers around the world rely on Schaeffer Center research and modeling tools for finding ways to help keep people as healthy as possible throughout their lives.
Our Experts On Lifespan Health and Aging
Our Work In Lifespan Health and Aging
-
Longitudinal Analysis of Dementia Diagnosis and Specialty Care Among Racially Diverse Medicare Beneficiaries
The burden of Alzheimer’s disease and other dementias is rapidly growing. Researchers found vast majority of dementia patients don’t receive specialty diagnosis and care.
-
Assessing the Preparedness of the Canadian Health Care System Infrastructure for an Alzheimer’s Treatment
A report on Canadian readiness to deal with new Alzheimer’s disease treatments co-authored by Jakub Hlávka found that average wait times could reach 28 months and that the most pressing issue is a lack of dementia specialists.
Categorized in -
Analysis of Dementia in the U.S. Population Using Medicare Claims: Insights From Linked Survey and Administrative Claims Data
Insufficient understanding of the completeness of dementia diagnosis and for whom in Medicare claims data limits their use. This study analyzes prevalence and incidence of dementia in survey and claims data to understand differences.
-
Research Spotlight: Alzheimer’s Disease
Schaeffer Center researchers are analyzing trends associated with a greying population, including AD prevalence and cost, and what these trends mean for society.
-
Material–Psychosocial–Behavioral Aspects of Financial Hardship: A Conceptual Model for Cancer Prevention
RCMAR Scientist Reginald Tucker-Seeley presents a model to consistently measure financial hardship to better inform cancer prevention research identify connections between socioeconomic circumstances and cancer risk-related behaviors and cancer screening among older adults.
-
Economic Dimensions of Personalized and Precision Medicine
The book explores recent empirical applications of personalized and precision medicine, as well as the intersection of the scientific, clinical, and economic factors affecting the development of PPM.